Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design
Sepsis is a devastating clinical condition that can lead to multiple organ failure and death. Despite advancements in our understanding of molecular mechanisms underlying sepsis and sepsis-associated multiple organ failure, no effective therapeutic treatment to directly counteract it has yet been es...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.867625/full |
| _version_ | 1817990173875503104 |
|---|---|
| author | Matthijs Luxen Matthijs Luxen Matijs van Meurs Matijs van Meurs Grietje Molema |
| author_facet | Matthijs Luxen Matthijs Luxen Matijs van Meurs Matijs van Meurs Grietje Molema |
| author_sort | Matthijs Luxen |
| collection | DOAJ |
| description | Sepsis is a devastating clinical condition that can lead to multiple organ failure and death. Despite advancements in our understanding of molecular mechanisms underlying sepsis and sepsis-associated multiple organ failure, no effective therapeutic treatment to directly counteract it has yet been established. The endothelium is considered to play an important role in sepsis. This review highlights a number of signal transduction pathways involved in endothelial inflammatory activation and dysregulated endothelial barrier function in response to sepsis conditions. Within these pathways – NF-κB, Rac1/RhoA GTPases, AP-1, APC/S1P, Angpt/Tie2, and VEGF/VEGFR2 – we focus on the role of kinases and phosphatases as potential druggable targets for therapeutic intervention. Animal studies and clinical trials that have been conducted for this purpose are discussed, highlighting reasons why they might not have resulted in the expected outcomes, and which lessons can be learned from this. Lastly, opportunities and challenges that sepsis and sepsis-associated multiple organ failure research are currently facing are presented, including recommendations on improved experimental design to increase the translational power of preclinical research to the clinic. |
| first_indexed | 2024-04-14T00:55:38Z |
| format | Article |
| id | doaj.art-9ff91488c0d8492e93efd85d8d671782 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-14T00:55:38Z |
| publishDate | 2022-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-9ff91488c0d8492e93efd85d8d6717822022-12-22T02:21:37ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-05-011310.3389/fimmu.2022.867625867625Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment DesignMatthijs Luxen0Matthijs Luxen1Matijs van Meurs2Matijs van Meurs3Grietje Molema4Department of Pathology and Medical Biology, Medical Biology Section, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Pathology and Medical Biology, Medical Biology Section, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Pathology and Medical Biology, Medical Biology Section, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsSepsis is a devastating clinical condition that can lead to multiple organ failure and death. Despite advancements in our understanding of molecular mechanisms underlying sepsis and sepsis-associated multiple organ failure, no effective therapeutic treatment to directly counteract it has yet been established. The endothelium is considered to play an important role in sepsis. This review highlights a number of signal transduction pathways involved in endothelial inflammatory activation and dysregulated endothelial barrier function in response to sepsis conditions. Within these pathways – NF-κB, Rac1/RhoA GTPases, AP-1, APC/S1P, Angpt/Tie2, and VEGF/VEGFR2 – we focus on the role of kinases and phosphatases as potential druggable targets for therapeutic intervention. Animal studies and clinical trials that have been conducted for this purpose are discussed, highlighting reasons why they might not have resulted in the expected outcomes, and which lessons can be learned from this. Lastly, opportunities and challenges that sepsis and sepsis-associated multiple organ failure research are currently facing are presented, including recommendations on improved experimental design to increase the translational power of preclinical research to the clinic.https://www.frontiersin.org/articles/10.3389/fimmu.2022.867625/fullendothelial cells (EC)sepsissepsis-induced organ injurysepsis-induced multiple organ failuredrug treatment, signal transductionkinases and phosphatases |
| spellingShingle | Matthijs Luxen Matthijs Luxen Matijs van Meurs Matijs van Meurs Grietje Molema Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design Frontiers in Immunology endothelial cells (EC) sepsis sepsis-induced organ injury sepsis-induced multiple organ failure drug treatment, signal transduction kinases and phosphatases |
| title | Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design |
| title_full | Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design |
| title_fullStr | Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design |
| title_full_unstemmed | Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design |
| title_short | Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design |
| title_sort | unlocking the untapped potential of endothelial kinase and phosphatase involvement in sepsis for drug treatment design |
| topic | endothelial cells (EC) sepsis sepsis-induced organ injury sepsis-induced multiple organ failure drug treatment, signal transduction kinases and phosphatases |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.867625/full |
| work_keys_str_mv | AT matthijsluxen unlockingtheuntappedpotentialofendothelialkinaseandphosphataseinvolvementinsepsisfordrugtreatmentdesign AT matthijsluxen unlockingtheuntappedpotentialofendothelialkinaseandphosphataseinvolvementinsepsisfordrugtreatmentdesign AT matijsvanmeurs unlockingtheuntappedpotentialofendothelialkinaseandphosphataseinvolvementinsepsisfordrugtreatmentdesign AT matijsvanmeurs unlockingtheuntappedpotentialofendothelialkinaseandphosphataseinvolvementinsepsisfordrugtreatmentdesign AT grietjemolema unlockingtheuntappedpotentialofendothelialkinaseandphosphataseinvolvementinsepsisfordrugtreatmentdesign |